In this episode of the Sports Pharmacy Network show, Brandon Welch, PharmD., and Jessica Beal-Stahl, PharmD., dive deep into the world of GLP-1s and GIP/GLP-1s, the hottest topic in weight loss today. Our episode connects the gap between medicine and athletics. We explore the relationship between GLP-1, energy metabolism, and muscle function.  As clinical sports pharmacists, we dissect the potential advantages and drawbacks of GLP-1, offering valuable perspectives for athletes. WADA has added semaglutide to the 2024 Monitoring List; we look further into Prohibited Substances and why athletes might abuse GLP-1s. In this episode, we unpack the essential information and empower athletes with the knowledge to make informed decisions about their health:

• Understanding GLP-1 (Semaglutide) and Diving into GIP/GLP-1s (Tirzapetide) - 3:47 and 11:24
• Unveiling the Connection of GLP-1 and Athlete Performance -  30:45
• Balancing Risks and Benefits: Focusing on Athletes - 14:25
• WADA: Understanding Banned Substances and Monitoring List - 34:20
• Awareness of Compounding and Online Pharmacy – 42:42
• Applications and Support for Athletes on GLP-1 - 50:36

Links:

• WADA Prohibited Drug List 2024 - https://www.wada-ama.org/en/resources/world-anti-doping-program/2024-prohibited-list
• GlobalDRO - https://globaldro.com/Homeal DRO - Home

Educated athletes make better decisions for their health and performance. This episode is designed to equip both medical professionals and athletes with the knowledge they need to navigate the complex landscape of GLP-1 in sports medicine.